EGFR and neoplasm: Thus, identifying a suitable tyrosine kinase inhibitor (TKI) with multiple functions in modulating the EGFR, KRAS, and mTOR pathways is important to reprogram tumor metabolism and reverse mitochondrial dysfunction.